financetom
Business
financetom
/
Business
/
Evacuation continues following Indonesia's Ruang volcano eruption
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Evacuation continues following Indonesia's Ruang volcano eruption
May 1, 2024 12:36 AM

JAKARTA, May 1 (Reuters) - Hundreds residents of

Indonesia's Tagulandang island were waiting at the island's port

to be evacuated on Wednesday, footage from National Search and

Rescue Agency showed, while grey smoke continued to erupt from

Ruang volcano.

Indonesia's Ruang volcano erupted on Tuesday, spewing lava

that prompted authorities to evacuate more than 12,000 people

from the nearby Tagulandang island.

The Center for Volcanology and Geological Hazard Mitigation

(PVMBG) raised the alert status of Ruang to the highest level

after yesterday's eruption, and warned the residents of

Tagulandang island that a tsunami could be triggered by volcanic

material collapsing into the ocean.

"Personnel of Manado Search and Rescue Agency are evacuating

109 Tagulandang residents to Munte port, while hundreds are

still waiting in Minanga port to be evacuated," the National

Search and Rescue agency said in a statement on Wednesday.

The residents will be evacuated to North Minahasa Regency on

Indonesia's Sulawesi island.

Transport authorities extended Manado's Sam Ratulangi

airport shutdown until noon (0400 GMT) on Thursday.

Meanwhile carrier AirAsia said in an Instagram post on

Wednesday that flights to and from several cities in Malaysia's

Borneo were affected by the eruption.

Ruang island is about 100 km from Manado, the capital of

North Sulawesi province in the north-central region of the

sprawling Indonesian archipelago.

Indonesia straddles the so-called "Pacific Ring of Fire," an

area of high seismic activity where multiple tectonic plates

meet.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Biogen Says Leqembi Approved in Australia as Treatment for Alzheimer's Disease; Shares Up Pre-Bell
Biogen Says Leqembi Approved in Australia as Treatment for Alzheimer's Disease; Shares Up Pre-Bell
Sep 24, 2025
08:11 AM EDT, 09/24/2025 (MT Newswires) -- Biogen (BIIB) and Eisai said Wednesday that Australia's Therapeutic Goods Administration approved Leqembi for the treatment of mild cognitive impairment and mild dementia due to Alzheimer's disease. The approval follows a review process after the regulatory agency initially did not approve the drug in February, the company said. Leqembi targets toxic protofibrils and...
Freeport-McMoRan expects lower consolidated sales for copper, gold in third quarter
Freeport-McMoRan expects lower consolidated sales for copper, gold in third quarter
Sep 24, 2025
Sept 24 (Reuters) - Miner Freeport-McMoRan said on Wednesday that it was expecting consolidated sales to be about 4% lower for copper and nearly 6% lower for gold in the third quarter, compared with its prior forecast. (Reporting by Pooja Menon in Bengaluru; Editing by Anil D'Silva) ...
Two US senators urge Tinder parent to act against dating scams on its apps
Two US senators urge Tinder parent to act against dating scams on its apps
Sep 24, 2025
(Reuters) -Two U.S. senators sent a letter to Tinder parent Match on Wednesday, pushing for action against dating scams on the company's platforms and asking for information about its efforts to detect frauds and protect its users. In a letter to Match CEO Spencer Rascoff, Democratic Senator Maggie Hassan and Republican Senator Marsha Blackburn asked the company to provide documents...
Harmony Biosciences' genetic disorder drug fails to meet main goal in late-stage trial
Harmony Biosciences' genetic disorder drug fails to meet main goal in late-stage trial
Sep 24, 2025
Sept 24 (Reuters) - Harmony Biosciences ( HRMY ) said on Wednesday its experimental drug for a type of rare genetic disorder failed to meet the main goal in a late-stage trial. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved